> In the 1990s a toxicologist named Alfred Wehner worked as an outside consultant for J&J. His official role was to help evaluate the research on ovarian cancer and talc and advise the company on its response. Unofficially, he was its scold. Wehner was on J&J’s side, but he was concerned that a cosmetics trade group (partly funded by the company) was mischaracterizing the scientific case for talc. “A true friend is not he who beguiles you with flattery but he who discloses to you your mistakes before your enemies discover them,” Wehner began a 1997 letter to Michael Chudkowski, J&J’s manager of preclinical toxicology. Wehner described statements on talc research from the group as inept, misleading, and outright false. Referring to a statement a few years earlier, he wrote: “At that time there had been about 9 studies (more by now) published in the open literature that did show a statistically significant association between hygienic talc use and ovarian cancer. Anybody who denies this risks that the talc industry will be perceived by the public like it perceives the cigarette industry: denying the obvious in the face of all evidence to the contrary.” He wanted the trade group to argue that the studies’ biological significance was questionable.
The UK National Health Service has a recent overview of the study that was used as evidence associating talc with ovarian cancer. They come to the conclusion that while there is some evidence of an association, there is as yet no firm evidence proving causation: http://www.nhs.uk/news/2016/03March/Pages/Talc-and-ovarian-c...
Glancing at it, it seems like a very professional writeup, with many appropriate disclaimers about possible confounders. The key statistic that I have not been able to find in the paper (although I presume it's in there somewhere) is the incidence rate of ovarian cancer among the 1000 control subjects. SEER says (http://seer.cancer.gov/statfacts/html/ovary.html) that 1.3% of women will be diagnosed with ovary cancer during their lives.
Since the control subjects haven't lived their entire lives, and since diagnosis is mostly in older women (age 63), I'd guess that they'd have only something like fewer than 10 subjects on the control side with ovarian cancer. I think this means that if by chance there happened to 2 or 3 more subjects with cancer on the control side, the 1.3 increase in risk would be reversed, and thus the evidence is extremely weak! Or am I wrong, and there is some way of determining the odds ratio without knowing the true incidence rate among the controls?
My personal take: a demonstration that the burden of proof in a scientific (or technological) sense is very different from the burden of proof in a legal sense.
This has always been the case. The standard for scientific proof in the natural sciences is often quite high, and the legal standard for tort claims is usually "preponderance of evidence", which you could think of as a P-value of 0.50. The lowest P-value acceptable in most scientific fields is 0.10, more common you would use 0.05, and particle physicists would use 0.0000003 (for announcing the discovery of a new particle).
p-values are especially dangerous if used by a statistician. They'll know best how to manipulate the charts and data to look good and fool laypeople. Motive and intent are the most important issues.
Maybe the US should do what the EU does and ban such substances the moment there is some proof that they may do harm, and the burden should be on the industry to prove without a doubt that they don't cause harm.
Instead, the US government is trying to do the opposite by repealing such policies in the EU and making them more like in the US where anything is accepted until millions get cancer from it.
J&J's annual revenue is $70B so $55M is what, 0.07% or something like that? They probably spend more on refilling their vending machines.
Or let's put it another way. Say you are making $100K, it would be like paying one $70 fine for giving someone cancer. A speeding violation will be more than that in most states.
As a sibling post mentioned already, your base salary is not pure profit either. Most goes to mortage payments, car payments, taxes etc. It is still a worthwhile comparison I think.
They knew talc caused cancer and not only covered it up, but turned their marketing to groups less likely to know about it. It's worse than the tobacco coverup, because everybody knew cigarettes were bad for you, just not how bad they actually were.
> but turned their marketing to groups less likely to know about it
It does appear that way, but it's not true. The marketing was simply toward those who buy it more often that's all.
Knowingly selling a dangerous product is bad enough (it says not to inhale the dust - how exactly are you supposed to use it without making dust?), but let's not criticize them for things that are not real.
How can J&J cover that up? Do they control that research? Were they interfering somehow (hush money, that sort of thing)?
Talc is an ancient, traditional material. They never hid the fact that their powder is made of talc. (And that is the selling point. I wouldn't buy some starch-based substitute myself.)
Alcohol turns to acetaldehyde, which is carcinogenic. Thus, sue the fuck everyone who produces wine, whisky, beer, sauerkraut or fermented anything. They are all covering it up by not mentioning cancer on their label!
https://en.wikipedia.org/wiki/Talc#Food_grade : The US Food and Drug Administration (FDA) considers talc (magnesium silicate) to be generally recognized as safe (GRAS) for use as an anti-caking agent in table salt in concentrations smaller than 2%.
I believe that is exactly what punitive damages are. J&J caused harm. Since it's not a criminal case, the punitive damages are punishment and a deterrent for them and others not to harm consumers.
If the implication is that they made more than $66BB USD in profit from the sale of talcum powder, I think you're overestimating dramatically.
JNJ's total annual earnings is around $15BB (from all products).
JNJ's total annual sales of talcum powder are around $400MM. It would take them ~150 years to SELL $60BB of talc, let alone have that amount of profit from talc.
Relevant quote:
> In the 1990s a toxicologist named Alfred Wehner worked as an outside consultant for J&J. His official role was to help evaluate the research on ovarian cancer and talc and advise the company on its response. Unofficially, he was its scold. Wehner was on J&J’s side, but he was concerned that a cosmetics trade group (partly funded by the company) was mischaracterizing the scientific case for talc. “A true friend is not he who beguiles you with flattery but he who discloses to you your mistakes before your enemies discover them,” Wehner began a 1997 letter to Michael Chudkowski, J&J’s manager of preclinical toxicology. Wehner described statements on talc research from the group as inept, misleading, and outright false. Referring to a statement a few years earlier, he wrote: “At that time there had been about 9 studies (more by now) published in the open literature that did show a statistically significant association between hygienic talc use and ovarian cancer. Anybody who denies this risks that the talc industry will be perceived by the public like it perceives the cigarette industry: denying the obvious in the face of all evidence to the contrary.” He wanted the trade group to argue that the studies’ biological significance was questionable.